Find, compare & contact
Pelacarsen API Manufacturers
Contact suppliers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Pelacarsen is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Pelacarsen or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Pelacarsen API 1637637-70-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Pelacarsen. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Pelacarsen
- Synonyms:
- AKCEA-APO(a)-LRx , IONIS-APO(a)-LRx , Isis-681257 (galnac3--conjugated aso targeting human lipoprotein (a)) free acid , Pelacarsen
- Cas Number:
- 1637637-70-7
- DrugBank number:
- DB16284
- Unique Ingredient Identifier:
- LSO9H7UZ90
General Description:
Pelacarsen, identified by CAS number 1637637-70-7, is a notable compound with significant therapeutic applications. Pelacarsen is under investigation in clinical trial NCT03070782 (Phase 2 Study of ISIS 681257 (Akcea-apo(a)-lrx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease).
Categories:
Pelacarsen is categorized under the following therapeutic classes: Nucleic Acids, Nucleotides, and Nucleosides, Nucleotides, Polynucleotides. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
